Akeso enrolls first patient in pivotal phase III trial of cadonilimab for perioperative treatment of resectable gastric cancer: Hong Kong Friday, August 22, 2025, 18:00 Hrs [IST] ...

Alpha1H shows benefit in non-muscle invasive bladder cancer, shrinking tumors and boosting the immune system with manageable ...

Levelle Nutrition Co-founder and CEO Linda Alvarez discusses the timely launch of Cycle Syncing Protein and its broader ...

Bayer Ag (UK) (($GB:0P6S)) announced an update on their ongoing clinical study. Bayer AG has launched a Phase 2 clinical ...

AbbVie ABBV holds a dominant position in the immunology market, which is being aided by strong sales of its two new ...

As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of ...

USD is seeking more than $293.5 million in funding for various projects over the years to come, for everything from ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...

In response to a proposal submitted by Ravenbhel Healthcare of the fixed dose combination (FDC) pulmonary drug Bilastine 10 ...

First-time disclosures session at ACS Fall 2025 reveals diverse candidates for treating sickle cell disease, heart failure, ...

Chronic diseases, such as diabetes, cardiovascular conditions, autoimmune disorders, and cancer, represent an escalating global health challenge, exerting ...

From sleepless nights during a full moon to changes in mood as the month progresses, many people believe the moon’s cycle has ...